The present research confirmed the effectiveness and security of curcumenol, but there remain some considerations and limits to our reports. For effectiveness, the systemic distribution of curcumenol after intraperitoneal injection was not assessed, Consequently there was an absence of immediate evidence the exceptional concentration of curcumenol attained the joint. In https://infigratinib99876.designi1.com/48677594/rad51-inhibitor-b02-fundamentals-explained